Navigation Links
Weikang Bio-Technology Announces Filing for NASDAQ Listing
Date:6/22/2010

HARBIN, China, June 22 /PRNewswire-Asia-FirstCall/ -- Weikang Bio-Technology Group Co., Inc. (OTC Bulletin Board: WKBT) ("Weikang" or the "Company"), a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company had filed an application to list its common stock on the NASDAQ Capital Market.

"This is an important milestone for Weikang as we continue to expand our business and broaden our market penetration," commented Mr. Yin Wang, Chairman and CEO of Weikang Bio-Technology Group. "NASDAQ is a prestigious senior exchange that is well suited for rapidly growing companies such as Weikang that meets its stringent listing requirements. If approved, the listing can help to broaden the Company's shareholder base, provide greater trading liquidity and raise the Company's profile in the investment community."

Weikang believes it satisfies the majority of the listing qualifications associated with this application. The application is subject to review by NASDAQ's Listing Qualifications Department for compliance with all NASDAQ Capital Market requirements. The Company's common stock will continue to trade on the OTC Bulletin Board under its current symbol, WKBT, until the Company is notified of its acceptance.

About Weikang Bio-Technology Group Co., Inc.

Weikang Bio-Technology Group Co., Inc. is principally engaged in developing, manufacturing and distributing Traditional Chinese Medicine (TCM), and health and nutritional supplements in China, in c
'/>"/>

SOURCE Weikang Bio-Technology Group Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Weikang Bio-Technology Reports First Quarter 2010 Financial Results
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014   NuAire , a manufacturer of ergonomically ... agreement with Hitachi Koki of Japan ... centrifuges in North America . NuAire will ... United States and Canada ... options and accessories, training, pricing, as well as after sale ...
(Date:1/14/2014)... N.Y. , Jan. 14, 2014   Oligomerix, ... development of disease modifying therapeutics for Alzheimer,s disease ... relocation of its corporate headquarters to ... 2014 and expanded lease agreement for additional laboratory ... Oligomerix, which is focused on the development of ...
(Date:1/14/2014)... Jan. 14, 2014   Evidera , a ... industry, announced that the Center for Drug Evaluation ... has released its first draft qualification guidance document ... development: Qualification of Exacerbations of Chronic Pulmonary ... Acute Bacterial Exacerbation of Chronic Bronchitis in Patients ...
Breaking Medicine Technology:NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... streams that were once safe to swim or fish in ... most likely a toxin -- called microcystin -- produced by ... University of Tennessee, Knoxville, is leading an effort to find ... water. Wilhelm has been awarded $183,000 for the ...
... therapies that can target specific cellular processes without causing adverse ... the Universities of Bristol and Lige in Belgium have discovered ... brain. The research, led by Professor Neil Marrion ... this week,s Proceedings of National Academy of Sciences ...
... , This press release is available in ... built in a mirror-inverted manner. They differ from each other ... the molecules that is referred to as chirality is of ... molecules like carbon dioxide or methane are not chiral, many ...
... type of therapy aimed at reversing the gene-silencing that ... small clinical trial conducted by researchers at the Johns ... patients who received a two-drug combination designed to restore ... the expected four months, and two patients showed complete ...
... HealthDay Reporter , WEDNESDAY, Nov. 9 (HealthDay News) -- ... the researchers appear to have successfully screened for a rare ... blood test. By performing a DNA analysis on a ... able to accurately identify a specific chromosomal irregularity called "fetal ...
... national initiative, IPAL-EM (Improving Palliative Care in Emergency Medicine) ... when seriously ill patients are admitted to the emergency ... of the palliative care in emergency medicine, integration of ... cultures and mindset. Supported by the Center to ...
Cached Medicine News:Health News:University of Tennessee microbiologist to develop biofilter to clean-up toxic water 2Health News:Scientists discover how to design drugs that could target particular nerve cells 2Health News:Flexible rack systems sort molecules 2Health News:Combination epigenetic therapy clinical trial results 2Health News:Combination epigenetic therapy clinical trial results 3Health News:Maternal Blood Test Might Spot Birth Defects More Safely 2Health News:Maternal Blood Test Might Spot Birth Defects More Safely 3Health News:IPAL-EM launches to improve palliative care in emergency medicine 2
Jaffe tying forceps is very delicate with smooth jaws, straight, 6 mm long platform. For 8-0 to 11-0 sutures....
Straight heavy shafts with 7 mm tying surface. Wide serrated handle, polished finish. Overall length 4.2 inches....
Tying forceps with 6.5 mm tying platform. Round handle with flats provide flexibility of round handle with the stability of a flat handle. Straight shafts. Overall length 3.9 inches....
Curved shafts with 4 mm tying platform. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.3 inches....
Medicine Products: